Milde, Till
Till Milde
VIAF ID: 256153775036861550000 ( Personal )
Permalink: http://viaf.org/viaf/256153775036861550000
Preferred Forms
- 100 1 _ ‡a Milde, Till
- 100 0 _ ‡a Till Milde
4xx's: Alternate Name Forms (2)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas | |
Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study | |
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia | |
role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM | |
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation | |
A study of regulatory challenges of paediatric oncology phase I/II trial submissions and guidance on protocol development | |
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma | |
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance |